Related Experiment Video
Updated: Jul 5, 2026

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model
Published on: August 11, 2023
Well-being during the menopausal transition and early postmenopause: a within-stage analysis
Kathleen Smith-DiJulio1, Nancy Fugate Woods, Ellen Sullivan Mitchell
1Department of Family and Child Nursing, School of Nursing, University of Washington, Seattle, Washington 98112-2135, USA. smithdijulio@comcast.net
Purpose:
To identify whether menopausal transition (MT)-related factors--including MT stage, hot flash severity, levels of estrone glucuronide (E1G) and follicle stimulating hormone (FSH); number of negative life events; or personal resources of mastery and social support--are associated with stage specific well-being.
Methods:
Women from the Seattle Midlife Women's Health Study (N=334) provided at least one annual health questionnaire and a menstrual calendar; a subset provided first morning voided urine specimens assayed for E1G and FSH. Descriptive statistics were calculated and Pearson's product-moment correlations were estimated.
Results:
Mean levels of well-being were the same across MT stages (4.1, range 1.8-5.9). Physiologic variables were not significantly correlated with well-being: E1G levels (r = - .11 to 0.16), FSH levels (r = - .17 to .20) and hot flash severity (r = - .07 to .05). Significant correlations were observed between well-being and number of negative life events (r = - .48 to - .33, p < or = 0.01), mastery (r = .51-.64, p < or = 0.01), and satisfaction with social support (r = .04 non-significant) to r =.41, (p < or = 0.01).
Conclusion:
The association of well-being with life events and personal resources, and not MT-related indicators, hormone levels or vasomotor symptoms, supports work by other researchers. Further study is needed to determine whether patterns of well-being vary across the MT, and if so, what might predict that variability.
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Menses Phase
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
Proliferative Phase
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
The Menstrual Cycle
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
